Skip to main content
SpringerLink
Log in

Radiation Cystitis: Acute and Chronic

  • Chapter
  • First Online:
Radiation Therapy for Pelvic Malignancy and its Consequences

Abstract

Radiotherapy (RT) is a standard treatment option and an essential component of multimodal organ sparing treatment for various malignancies in the pelvis including cancers of the prostate, uterine cervix, rectum, and urinary bladder. Malignancies originating in these organs constitute up to 18% of all cancers. Due to its anatomic location, the urinary bladder is frequently exposed to radiation during treatment for pelvic cancers giving rise to a variety of urinary adverse effects. The acute effects of radiation on urothelium are characterized by mucosal edema, hyperemia, and inflammation. Acute lower urinary tract symptoms due to radiation can be irritative or obstructive. Irritative symptoms include urinary frequency, urgency, dysuria, and nocturia. Obstructive symptoms include weak urinary stream, hesitancy, and incomplete bladder emptying or complete bladder obstruction. Late damage is irreversible and is characterized by epithelial denudation, and ulceration with focal hyperplasia and fibrosis. In contrast to acute toxicity, late manifestations tend to be chronic and irreversible. Patients with a severely contracted bladder present with debilitating urinary frequency and incontinence. Another chronic manifestation of pelvic RT is late recurrent hematuria or hemorrhagic cystitis, defined as acute or insidious diffuse vesical bleeding that can sometimes be life threatening. A variety of scoring systems have been developed to assess the severity of bladder damage from radiation injury.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cancer Facts & Figs. 2009 Atlanta: American Cancer Society; 2009.

    Google Scholar 

  2. Elliott SP, Jarosek SA, Virnig BA. Unpublished analysis of SEER public use file1992–2006.

    Google Scholar 

  3. Stewart FA. The proliferative and functional response of mouse bladder to treatment with radiation and cyclophosphamide. Radiother Oncol. 1985;4:353–62.

    Article  CAS  PubMed  Google Scholar 

  4. Stewart FA. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer Suppl. 1986;7:280–91.

    PubMed Central  CAS  PubMed  Google Scholar 

  5. Stewart FA, Denekamp J, Hirst DG. Proliferation kinetics of the mouse bladder after Irradiation. Cell Tissue Kinet. 1980;13:75–89.

    CAS  PubMed  Google Scholar 

  6. Farsund T. Cell kinetics of mouse urinary bladder epithelium. I. Circadian and age variations in cell proliferation and nuclear DNA content. Virchows Arch B Cell Pathol. 1975;18:35–49.

    CAS  PubMed  Google Scholar 

  7. Jaal J, Dorr W. Radiation induced damage to mouse urothelial barrier. Radiother Oncol. 2006;80:250–6.

    Article  CAS  PubMed  Google Scholar 

  8. Dorr W, Ehme A, Koi S. Effects of acetylic salicylic acid (ASA) on acute radiation damage in mouse urinary bladder. Radiother Oncol. 1998;48:S108.

    Google Scholar 

  9. Stewart FA, Lundbeck F, Oussoren Y, et al. Acute and late radiation damage in mouse bladder: a comparison of urination frequency and cystometry. Int J Radiat Oncol Biol Phys. 1991;21:1211–9.

    Article  CAS  PubMed  Google Scholar 

  10. Kraft M, Oussoren Y, Stewart FA, Dorr W, Schultz-Hector S. Radiation-induced changes in transforming growth factor-beta and collagen expression in murine bladder wall and its correlation with bladder function. Radiat Res. 1996;146:619–27.

    Article  CAS  PubMed  Google Scholar 

  11. Jaal J, Bruchner K, Hoinkis C, Dorr W. Radiation-induced variations in urothelial expression of intercellular adhesion molecule 1 (ICAM-1): association with changes in urinary bladder function. Int J Radiat Biol. 2004;80:65–72.

    Article  CAS  PubMed  Google Scholar 

  12. Antonokopoulos GN, Hicks RM, Berry RJ. The subcellular basis of damage to the human urinary bladder induced by radiation. J Pathol. 1984;143:103–16.

    Article  Google Scholar 

  13. Turesson I. Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity. Radiother Oncol. 1991;11:349–360.

    Google Scholar 

  14. Lundbeck F, Ulso N, Overgaard J. Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder. Radiother Oncol. 1989;15:383–92.

    Article  CAS  PubMed  Google Scholar 

  15. Amdur RJ, Parsons JT, Fitzgerald LT, et al. Adenocarcinoma of prostate treated with external-beam radiation therapy. 5-year minimum follow-up. Radiother Oncol. 1990;18:235–46.

    Article  CAS  PubMed  Google Scholar 

  16. Quilty PM, Duncan W, Kerr GR. Results of a radomized study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol. 1985;36:615–8.

    Article  CAS  PubMed  Google Scholar 

  17. Sack H, Nosbuesch H, Stuetzer H. Radiotherapy of prostate carcinoma. Results of treatment and complications. Radiotehr Oncol. 1987;10:7–15.

    Article  CAS  Google Scholar 

  18. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.

    Article  CAS  PubMed  Google Scholar 

  19. National Cancer Institute, Common terminology criteria for Adverse Events, Version 4.0, NCI, NIH, DHHS, May 29, 2009. NIH Publication #09–7473.

    Google Scholar 

  20. Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7:206–14.

    Article  PubMed  Google Scholar 

  21. Barry MJ, Fowler FJ Jr, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol. 1992;148:1549–57.

    CAS  PubMed  Google Scholar 

  22. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol. 1999;17:517–22.

    CAS  PubMed  Google Scholar 

  23. Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 1999;85(11):2460–8.

    Article  CAS  PubMed  Google Scholar 

  24. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294(10):1233–9.

    Article  CAS  PubMed  Google Scholar 

  25. Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 1991;21:935–9.

    Article  CAS  PubMed  Google Scholar 

  26. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24:1990–6.

    Article  PubMed  Google Scholar 

  27. Gardner BG, Zietman AL, Shipley WU, et al. Late normal tissue sequelae in the second decade after high-dose radiation therapy with combimed photons and conformal protons for locally advanced prostate cancer. J Urol. 2002;167:123–6.

    Article  CAS  PubMed  Google Scholar 

  28. Sarosdy MF. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Cancer. 2004;101:754–60.

    Article  PubMed  Google Scholar 

  29. Chen AB, D’Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol. 2006;24:5298–304.

    Article  PubMed  Google Scholar 

  30. Gogna NK, Matthews JH, Turner SL, et al. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group. Radiother Oncol. 2006;81:9–17.

    Article  CAS  PubMed  Google Scholar 

  31. Fokdal L, Hoyer M, Meldgaard P, von der Maase H. Longterm bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol. 2004;72:139–45.

    Article  PubMed  Google Scholar 

  32. Hoskin PJ, Rojas AM, Phillips H, Saunders MI. Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. Cancer. 2005;103:2287–97.

    Article  PubMed  Google Scholar 

  33. Kaufman DS, Winter KA, Shipley WU, et al. Phase I-II RTOG study (99–06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. Urology. 2009;73:833–7.

    Article  PubMed  Google Scholar 

  34. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.

    Article  CAS  PubMed  Google Scholar 

  35. McIntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995;75:836–43.

    Article  CAS  PubMed  Google Scholar 

  36. Takeshi K, Katsuyuki K, Yoshiaki T, et al. Definitive radiotherapy combined with high-dose-rate brachytherapy for Stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys. 1998;41:319–27.

    Article  CAS  PubMed  Google Scholar 

  37. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995;32:1289–1300.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, UCI Medical Center, 333 City Blvd West, Suite 2100, Orange, 92868, CA, USA

    Surendra B. Kolla MD

  2. Department of Urology, University of Washington, 2133 102nd Place SE, Bellevue, WA, 98004, USA

    Prof. Atreya Dash MD

Authors
  1. Surendra B. Kolla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Atreya Dash MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atreya Dash MD .

Editor information

Editors and Affiliations

  1. University of Chicago Medical School, NorthShore University Health System, Highland Park, Illinois, USA

    Eli Daniel Ehrenpreis

  2. University of Chicago Pritzker School of Medicine, NorthShore University Health System, Highland Park, Illinois, USA

    R de W Marsh

  3. Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, Illinois, USA

    William Small Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kolla, S., Dash, A. (2015). Radiation Cystitis: Acute and Chronic. In: Ehrenpreis, E., Marsh, R., Small Jr., W. (eds) Radiation Therapy for Pelvic Malignancy and its Consequences. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2217-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2217-8_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2216-1

  • Online ISBN: 978-1-4939-2217-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation